Anavex Life Sciences
AVXL
#9984
Rank
โ‚ฌ68.82 M
Marketcap
0,74ย โ‚ฌ
Share price
-12.42%
Change (1 day)
-75.91%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -โ‚ฌ10.95 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ36.32 Million, an increase over its 2024 earnings that were of -โ‚ฌ46.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ10.95 Million-69.86%
2025 -โ‚ฌ36.32 Million-22.43%
2024 -โ‚ฌ46.82 Million14.77%
2023 -โ‚ฌ40.8 Million-17.49%
2022 -โ‚ฌ49.44 Million22.96%
2021 -โ‚ฌ40.21 Million35.36%
2020 -โ‚ฌ29.71 Million12.65%
2019 -โ‚ฌ26.37 Million29.09%
2018 -โ‚ฌ20.43 Million36.33%
2017 -โ‚ฌ14.99 Million17.11%
2016 -โ‚ฌ12.8 Million20.91%
2015 -โ‚ฌ10.59 Million-6.29%
2014 -โ‚ฌ11.3 Million337.28%
2013 -โ‚ฌ2.59 Million
2008 -โ‚ฌ4.78 Million106.01%
2007 -โ‚ฌ2.32 Million8848.98%
2006 -โ‚ฌ0.03 Million-79.99%
2005 -โ‚ฌ0.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚ฌ55.31 M-570.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚ฌ0.10 B-956.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ7.61 Million-35.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ0.33 Billion 2,638.61%๐Ÿ‡บ๐Ÿ‡ธ USA